Presented by Ellen Schur, MD, MS Professor, Division of General Internal Medicine
University of Washington School of Medicine
Clinical Research Director, UW Medicine Diabetes Institute
In this episode of Science Quickly, Scientific American’s associate health editor Lauren Young joins host Kendra Pierre-Louis to talk about how the story of GLP‑1 drugs such as Ozempic, Wegovy and Mounjaro is evolving. We trace GLP-1s’ origins as type 2 diabetes treatments, their rise as blockbuster weight‑loss medications and the ensuing complications—including the expanding market for compounded drugs. And we look at how the landscape has only grown more complex as researchers explore surprising potential uses for GLP‑1s, from addiction treatment to...
ExcelMale Newsletter Signup
Stay Informed with Our Newsletter
Get the latest men's health insights, expert advice, and community updates delivered to your inbox.